Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Once Daily Darunavir/Ritonavir in HIV-infected Children 6-12 Years Old: a Pharmacokinetic Validation of Model Based Dosing Recommendations

NCT02285478 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT02285478
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02285478 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Once Daily Darunavir/Ritonavir in HIV-infected Children 6-12 Years Old: a Pharmacokinetic Validation of Model Based Dosing Recommendations
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Completed
Start date
March 31, 2015
Completion date
July 31, 2016
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

children, human immunodeficiency virus